No abstract available
Keywords:
Anti PD1; Immune checkpoint inhibitors; Immune related adverse effects; Myositis; Nivolumab.
Publication types
-
Case Reports
-
Letter
-
Review
MeSH terms
-
Adenocarcinoma / drug therapy
-
Aged
-
Antigens, CD / metabolism
-
Antineoplastic Agents, Immunological / adverse effects*
-
Electromyography
-
Humans
-
Lung Neoplasms / drug therapy
-
Male
-
Muscle, Skeletal / pathology
-
Myositis / chemically induced*
-
Nivolumab / adverse effects*
Substances
-
Antigens, CD
-
Antineoplastic Agents, Immunological
-
Nivolumab